BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31879127)

  • 1. Acetylation of SUMO1 Alters Interactions with the SIMs of PML and Daxx in a Protein-Specific Manner.
    Mascle XH; Gagnon C; Wahba HM; Lussier-Price M; Cappadocia L; Sakaguchi K; Omichinski JG
    Structure; 2020 Feb; 28(2):157-168.e5. PubMed ID: 31879127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional characterization of the phosphorylation-dependent interaction between PML and SUMO1.
    Cappadocia L; Mascle XH; Bourdeau V; Tremblay-Belzile S; Chaker-Margot M; Lussier-Price M; Wada J; Sakaguchi K; Aubry M; Ferbeyre G; Omichinski JG
    Structure; 2015 Jan; 23(1):126-138. PubMed ID: 25497731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc controls PML nuclear body formation through regulation of a paralog specific auto-inhibition in SUMO1.
    Lussier-Price M; Wahba HM; Mascle XH; Cappadocia L; Bourdeau V; Gagnon C; Igelmann S; Sakaguchi K; Ferbeyre G; Omichinski JG
    Nucleic Acids Res; 2022 Aug; 50(14):8331-8348. PubMed ID: 35871297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a C-Terminal SUMO-Interacting Motif Present in Select PIAS-Family Proteins.
    Lussier-Price M; Mascle XH; Cappadocia L; Kamada R; Sakaguchi K; Wahba HM; Omichinski JG
    Structure; 2020 May; 28(5):573-585.e5. PubMed ID: 32348746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1.
    Brown JR; Conn KL; Wasson P; Charman M; Tong L; Grant K; McFarlane S; Boutell C
    J Virol; 2016 Jul; 90(13):5939-5952. PubMed ID: 27099310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An acetylation switch regulates SUMO-dependent protein interaction networks.
    Ullmann R; Chien CD; Avantaggiati ML; Muller S
    Mol Cell; 2012 Jun; 46(6):759-70. PubMed ID: 22578841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PML is recruited to heterochromatin during S phase and represses DAXX-mediated histone H3.3 chromatin assembly.
    Shastrula PK; Sierra I; Deng Z; Keeney F; Hayden JE; Lieberman PM; Janicki SM
    J Cell Sci; 2019 Mar; 132(6):. PubMed ID: 30796101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The promyelocytic leukemia protein isoform PML1 is an oncoprotein and a direct target of the antioxidant sulforaphane (SFN).
    Alhazmi N; Pai CP; Albaqami A; Wang H; Zhao X; Chen M; Hu P; Guo S; Starost K; Hajihassani O; Miyagi M; Kao HY
    Biochim Biophys Acta Mol Cell Res; 2020 Aug; 1867(8):118707. PubMed ID: 32243901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing the N- and C-terminal Small ubiquitin-like modifier (SUMO)-interacting motifs of the scaffold protein DAXX.
    Escobar-Cabrera E; Okon M; Lau DK; Dart CF; Bonvin AM; McIntosh LP
    J Biol Chem; 2011 Jun; 286(22):19816-29. PubMed ID: 21383010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daxx Inhibits HIV-1 Reverse Transcription and Uncoating in a SUMO-Dependent Manner.
    Maillet S; Fernandez J; Decourcelle M; El Koulali K; Blanchet FP; Arhel NJ; Maarifi G; Nisole S
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32545337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional roles of Daxx SIM phosphorylation in SUMO paralog-selective binding and apoptosis modulation.
    Chang CC; Naik MT; Huang YS; Jeng JC; Liao PH; Kuo HY; Ho CC; Hsieh YL; Lin CH; Huang NJ; Naik NM; Kung CC; Lin SY; Chen RH; Chang KS; Huang TH; Shih HM
    Mol Cell; 2011 Apr; 42(1):62-74. PubMed ID: 21474068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1.
    Ishov AM; Sotnikov AG; Negorev D; Vladimirova OV; Neff N; Kamitani T; Yeh ET; Strauss JF; Maul GG
    J Cell Biol; 1999 Oct; 147(2):221-34. PubMed ID: 10525530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required for varicella-zoster virus pathogenesis in skin.
    Wang L; Oliver SL; Sommer M; Rajamani J; Reichelt M; Arvin AM
    PLoS Pathog; 2011 Aug; 7(8):e1002157. PubMed ID: 21901090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubility changes of promyelocytic leukemia (PML) and SUMO monomers and dynamics of PML nuclear body proteins in arsenite-treated cells.
    Hirano S; Udagawa O; Kobayashi Y; Kato A
    Toxicol Appl Pharmacol; 2018 Dec; 360():150-159. PubMed ID: 30292834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.
    Meinecke I; Cinski A; Baier A; Peters MA; Dankbar B; Wille A; Drynda A; Mendoza H; Gay RE; Hay RT; Ink B; Gay S; Pap T
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5073-8. PubMed ID: 17360386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of two independent SUMO-interacting motifs in Daxx: evolutionary conservation from Drosophila to humans and their biochemical functions.
    Santiago A; Godsey AC; Hossain J; Zhao LY; Liao D
    Cell Cycle; 2009 Jan; 8(1):76-87. PubMed ID: 19106612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
    Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
    Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML.
    Fasci D; Anania VG; Lill JR; Salvesen GS
    Sci Signal; 2015 Jun; 8(380):ra56. PubMed ID: 26060329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16.
    Bund T; Spoden GA; Koynov K; Hellmann N; Boukhallouk F; Arnold P; Hinderberger D; Florin L
    Cell Microbiol; 2014 Aug; 16(8):1179-200. PubMed ID: 24444361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Analysis of a Complex between Small Ubiquitin-like Modifier 1 (SUMO1) and the ZZ Domain of CREB-binding Protein (CBP/p300) Reveals a New Interaction Surface on SUMO.
    Diehl C; Akke M; Bekker-Jensen S; Mailand N; Streicher W; Wikström M
    J Biol Chem; 2016 Jun; 291(24):12658-12672. PubMed ID: 27129204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.